BIOX

Bioceres Crop Solutions Corp. [BIOX] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

BIOX Stock Summary

Earnings have grown 27.7% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

EPS has increased from the previous year and become positive (Yearly statements)

EPS has increased from the previous quarter and is now positive. (Quarter statements)

In the last year, shareholders have seen their holdings diluted. Dilution over past year is 53.55%

Earnings are expected to fall -100% next year

Profit margins (0.03%) are lower than the previous year (0.04%)

BIOX has less than 1 year of cash runway

Top 10 Correlated ETFs

BIOX

Top 10 Correlated Stocks

BIOX

In the News

BIOX Financial details

Company Rating

Buy

Market Cap

785.35M

Income

21.95M

Revenue

454.54M

Book val./share

4.78

Cash/share

0.66

Dividend

Dividend %

Employees

400

Optionable

Shortable

Yes

Earnings

08 May 2024

P/E

74.9

Forward P/E

PEG

-2.44

P/S

2.07

P/B

2.83

P/C

18.53

P/FCF

-42.45

Quick Ratio

0.82

Current Ratio

1.27

Debt / Equity

0.79

LT Debt / Equity

0.36

EPS (TTM)

0.35

EPS next Y

EPS next Q

EPS this Y

-276.47%

EPS next Y

EPS next 5Y

EPS last 5Y

NAN%

Revenue last 5Y

21.21%

Revenue Q/Q

20.76%

EPS Q/Q

-102.33%

SMA20

-3.03%

SMA50

-4.88%

SMA100

7.4%

Inst Own

7.44%

Inst Trans

0.54%

ROA

ROE

ROC

0.08%

Gross Margin

43%

Oper. Margin

10%

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

9.76-14.2

52W High

-12.64%

52W Low

+35.89%

RSI

32.75

Rel Volume

0.58

Avg Volume

66.91K

Volume

39.12K

Perf Week

-2.24%

Perf Month

-6.14%

Perf Quarter

15.49%

Perf Half Y

16.37%

Beta

0.584

Volatility

0.11%, 0.21%

Prev Close

-1.77%

Price

12.23

Change

-1.37%

BIOX Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	5.26	4.77	5.27	7.76	6.75
Net income per share	-0.6	0.09	-0.18	-0.17	0.3
Operating cash flow per share	0.97	0.26	-0.16	-0.41	0.04
Free cash flow per share	0.86	0.13	-0.51	-0.63	-0.32
Cash per share	0.12	1.43	1.19	0.91	0.97
Book value per share	1.55	1.28	1.73	3.02	4.81
Tangible book value per share	-0.24	0	-0.15	1.08	0.72
Share holders equity per share	1.55	1.28	1.73	3.02	4.81
Interest debt per share	4.11	4.66	4.93	4.37	4.48
Market cap	160.01M	218.89M	551.02M	579.96M	830.27M
Enterprise value	260.12M	325.46M	689.55M	716.28M	1.04B
P/E ratio	-8.71	65.16	-80.21	-80.55	44.21
Price to sales ratio	1	1.27	2.67	1.77	1.98
POCF ratio	5.39	23.49	-88.79	-33.11	320.72
PFCF ratio	6.1	45.45	-27.37	-21.87	-41.57
P/B Ratio	3.38	4.74	8.13	4.54	2.78
PTB ratio	3.38	4.74	8.13	4.54	2.78
EV to sales	1.62	1.89	3.34	2.18	2.48
Enterprise value over EBITDA	17.19	6.13	16.08	15.02	14.37
EV to operating cash flow	8.76	34.93	-111.11	-40.89	401.56
EV to free cash flow	9.91	67.57	-34.26	-27.02	-52.04
Earnings yield	-0.11	0.02	-0.01	-0.01	0.02
Free cash flow yield	0.16	0.02	-0.04	-0.05	-0.02
Debt to equity	2.19	3.23	2.58	1.33	0.86
Debt to assets	0.43	0.5	0.44	0.33	0.31
Net debt to EBITDA	6.62	2.01	3.23	2.86	2.89
Current ratio	0.84	1.26	1.26	1.34	1.33
Interest coverage	1.47	2.02	2.03	2.67	2.55
Income quality	-1.82	2.2	1.62	4.48	0.13
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	-0.15	0	0
Sales general and administrative to revenue	0.16	0.14	0.14	0.13	0.17
Research and developement to revenue	0.02	0.02	0.03	0.02	0.04
Intangibles to total assets	0.29	0.2	0.24	0.22	0.35
Capex to operating cash flow	-0.12	-0.48	2.24	0.51	-8.72
Capex to revenue	-0.02	-0.03	-0.07	-0.03	-0.05
Capex to depreciation	-0.71	-0.95	-2.22	-0.98	-1.16
Stock based compensation to revenue	0	0.02	0.01	0	0.01
Graham number	4.59	1.64	2.61	3.4	5.72
ROIC	0.37	0.13	-0.06	-0.04	0.1
Return on tangible assets	-0.11	0.01	-0.02	-0.02	0.04
Graham Net	-3.82	-3.09	-3.86	-3.83	-3.51
Working capital	-18.25M	34.08M	43.45M	75.04M	98.4M
Tangible asset value	-7.33M	-110.84K	-5.8M	45.52M	44.55M
Net current asset value	-82.16M	-72.12M	-92.81M	-62.22M	-90.45M
Invested capital	2.19	3.23	2.58	1.33	0.86
Average receivables	60.34M	69.98M	88.56M	113.61M	156.7M
Average payables	31.29M	45.31M	61.51M	96.83M	135.33M
Average inventory	23.48M	28.95M	46.83M	94.73M	133.34M
Days sales outstanding	141.13	165.12	175.08	142.33	161.26
Days payables outstanding	155.21	211.31	218.25	224.77	223.18
Days of inventory on hand	116.18	119.12	199.66	227.84	214.51
Receivables turnover	2.59	2.21	2.08	2.56	2.26
Payables turnover	2.35	1.73	1.67	1.62	1.64
Inventory turnover	3.14	3.06	1.83	1.6	1.7
ROE	-0.39	0.07	-0.1	-0.06	0.06
Capex per share	-0.11	-0.12	-0.36	-0.21	-0.36

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q2

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	1.53	1.5	1.67	1.85	2.23
Net income per share	-0.13	0.45	-0.03	-0.07	0
Operating cash flow per share	0.67	0.04	-0.14	0.23	0.21
Free cash flow per share	0.59	-0.06	-0.24	0.14	0.14
Cash per share	1.42	1.14	0.96	0.68	0.66
Book value per share	4.42	4.86	4.76	4.76	4.78
Tangible book value per share	0.16	0.6	0.71	0.75	0.8
Share holders equity per share	4.42	4.86	4.76	4.76	4.78
Interest debt per share	4.56	4.34	4.19	3.93	3.88
Market cap	741.74M	719.84M	838.96M	709.54M	862.79M
Enterprise value	944.21M	926.01M	1.05B	921.14M	1.07B
P/E ratio	-22.73	6.39	-122.83	-38.63	2.16K
Price to sales ratio	7.85	7.74	7.98	6.11	6.15
POCF ratio	17.99	320.01	-98.8	48.16	63.97
PFCF ratio	20.49	-187	-55.72	81.22	98.73
P/B Ratio	2.72	2.39	2.81	2.37	2.87
PTB ratio	2.72	2.39	2.81	2.37	2.87
EV to sales	9.99	9.96	9.98	7.93	7.66
Enterprise value over EBITDA	123.06	26.86	-341.7	97.32	72.63
EV to operating cash flow	22.9	411.67	-123.45	62.52	79.71
EV to free cash flow	26.08	-240.56	-69.62	105.44	123.01
Earnings yield	-0.01	0.04	0	-0.01	0
Free cash flow yield	0.05	-0.01	-0.02	0.01	0.01
Debt to equity	0.99	0.88	0.86	0.8	0.79
Debt to assets	0.31	0.31	0.31	0.29	0.29
Net debt to EBITDA	26.39	5.98	-68.22	22.36	14.34
Current ratio	1.36	1.39	1.33	1.27	1.23
Interest coverage	0.22	5.44	0.89	0.75	2.3
Income quality	-4.89	0.08	3.04	-5.5	124.36
Dividend Yield	0	0	0	0	0
Payout ratio	-0.03	0	0	0	0
Sales general and administrative to revenue	0	0	0	0.19	0
Research and developement to revenue	0.04	0.04	0.04	0.04	0.02
Intangibles to total assets	0.34	0.35	0.35	0.35	0.35
Capex to operating cash flow	-0.12	-2.71	0.77	-0.41	-0.35
Capex to revenue	-0.05	-0.07	-0.06	-0.05	-0.03
Capex to depreciation	-0.92	-1.22	-1.49	-1.24	-0.97
Stock based compensation to revenue	0.02	0.01	0.01	0.05	0
Graham number	3.63	7.04	1.71	2.8	0.41
ROIC	0	0.06	0.01	0.01	0
Return on tangible assets	-0.01	0.05	0	-0.01	0
Graham Net	-4.08	-3.63	-3.48	-3.47	-3.33
Working capital	120.63M	118.42M	98.4M	83.72M	73.7M
Tangible asset value	9.67M	37.45M	44.55M	47.43M	50.3M
Net current asset value	-115.01M	-91.29M	-90.45M	-91.65M	-90.1M
Invested capital	0.99	0.88	0.86	0.8	0.79
Average receivables	179.85M	192.3M	186.13M	196.76M	216.95M
Average payables	147.2M	153.25M	145.74M	150.02M	158.89M
Average inventory	150.58M	155.57M	146.74M	139.9M	131.91M
Days sales outstanding	188.14	180.95	158.74	161.27	144.78
Days payables outstanding	238.78	356.84	198.34	190.5	166.22
Days of inventory on hand	234.26	375.7	190.63	172.46	126.28
Receivables turnover	0.48	0.5	0.57	0.56	0.62
Payables turnover	0.38	0.25	0.45	0.47	0.54
Inventory turnover	0.38	0.24	0.47	0.52	0.71
ROE	-0.03	0.09	-0.01	-0.02	0
Capex per share	-0.08	-0.1	-0.1	-0.1	-0.08

BIOX Frequently Asked Questions

What is Bioceres Crop Solutions Corp. stock symbol ?

Bioceres Crop Solutions Corp. is a AR stock and trading under the symbol BIOX

What is Bioceres Crop Solutions Corp. stock quote today ?

Bioceres Crop Solutions Corp. stock price is $12.23 today.

Is Bioceres Crop Solutions Corp. stock public?

Yes, Bioceres Crop Solutions Corp. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 66.91K
Market Capitalization 785.35M
Employee 400
CEO Dr. Federico Trucco Ph.D.
Headquarters Rosario,AR
IPO Date 2018-03-22
Website https://biocerescrops.com

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.